Molina Healthcare, Inc. (MOH)
| Market Cap | 9.13B -48.6% |
| Revenue (ttm) | 43.10B +7.0% |
| Net Income | 188.00M -84.0% |
| EPS | 3.60 -82.6% |
| Shares Out | 52.09M |
| PE Ratio | 48.74 |
| Forward PE | 30.04 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 119,214 |
| Open | 178.44 |
| Previous Close | 178.02 |
| Day's Range | 175.00 - 178.44 |
| 52-Week Range | 121.06 - 311.53 |
| Beta | 0.85 |
| Analysts | Hold |
| Price Target | 186.63 (+6.46%) |
| Earnings Date | Apr 22, 2026 |
About MOH
Molina Healthcare, Inc. provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces in the United States. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company was founded in 1980 and is headquartered in Long Beach, California.
Financial Performance
In 2025, Molina Healthcare's revenue was $43.56 billion, an increase of 11.23% compared to the previous year's $39.16 billion. Earnings were $472.00 million, a decrease of -59.97%.
Financial StatementsAnalyst Summary
According to 18 analysts, the average rating for MOH stock is "Hold." The 12-month stock price target is $186.63, which is an increase of 6.46% from the latest price.
News
Molina Healthcare Opens One Stop Help Center in Albuquerque to Support Local Families
ALBUQUERQUE, N.M.--(BUSINESS WIRE)--Molina Healthcare opens One Stop Help Center in Albuquerque to support local families.
Molina Healthcare price target raised to $199 from $161 at Barclays
Barclays analyst Andrew Mok raised the firm’s price target on Molina Healthcare (MOH) to $199 from $161 and keeps an Underweight rating on the shares. The firm believes the managed…
Molina Healthcare price target raised to $202 from $180 at UBS
UBS raised the firm’s price target on Molina Healthcare (MOH) to $202 from $180 and keeps a Neutral rating on the shares. Managed care organizations broadly raised guidance after stronger-than-expecte...
Centene price target raised to $72 from $60 at BofA
BofA raised the firm’s price target on Centene (CNC) to $72 from $60 and keeps a Buy rating on the shares. The firm is “bullish” on and Molina Healthcare (MOH)…
Molina Healthcare and The MolinaCares Accord Donate $120,000 to Support Programming for Young Adults with Disabilities
LAWRENCE, Mass.--(BUSINESS WIRE)--Molina Healthcare and The MolinaCares Accord donate $120,000 to support programming for young adults with disabilities.
Molina Healthcare price target raised to $205 from $180 at Truist
Truist raised the firm’s price target on Molina Healthcare (MOH) to $205 from $180 and keeps a Hold rating on the shares after the company’s upbeat investor day. The company’s…
Molina Healthcare of Michigan and The MolinaCares Accord Donate $130,000 to Libraries for Pilot Programs Addressing Senior Social Isolation
LANSING, Mich.--(BUSINESS WIRE)--Molina Healthcare of Michigan and The MolinaCares Accord donate $130,000 to libraries for pilot programs addressing senior social isolation.
Molina Healthcare price target raised to $163 from $124 at Baird
Baird analyst Michael Ha raised the firm’s price target on Molina Healthcare (MOH) to $163 from $124 and keeps a Neutral rating on the shares. The firm updated its model…
Molina forecasts fivefold jump in 2029 profit if medical costs remain steady
Molina Healthcare on Friday forecast its 2029 adjusted profit to be about five times its current 2026 outlook, given the health insurer is able to keep its medical costs in check.
Molina Healthcare backs FY26 adjusted EPS view of greater than $5.00
Consensus $5.18. In investor day slides, the company stated: “With strong 1Q26 performance, full year 2026 guidance is reaffirmed.”
Molina sees premium growth of 14% to about $48B in 2027
“Strong premium growth of 14% to ~$48 billion in 2027 is driven by embedded future revenue,” Molina Healthcare (MOH) states in investor day slides.
Molina Healthcare targets 2029 adjusted EPS $20-$30
Targets 2029 total premium of about $64B. Guidance from investor day slides.
Molina Healthcare Transcript: Investor Day 2026
Premium revenue is projected to grow from $42B to $64B by 2029, driven by balanced organic growth, new contracts, and M&A, with a focus on margin restoration and operational discipline. Margin recovery targets a 2.5% pre-tax margin and $25 EPS, supported by embedded earnings and efficiency gains.
Molina Healthcare Slides: FY 2026
Molina Healthcare has posted slides in relation to its FY 2026 quarterly earnings report, which was published on May 8, 2026.
Molina Healthcare double upgraded to Buy from Underperform at BofA
As previously reported, BofA upgraded Molina Healthcare (MOH) to Buy from Underperform with a price target of $250, up from $152, due to Medicaid margins likely bottoming in 2026. The…
Molina Healthcare upgraded to Buy from Underperform at BofA
BofA analyst Kevin Fischbeck upgraded Molina Healthcare (MOH) to Buy from Underperform with a price target of $250, up from $152.
Molina Healthcare price target raised to $180 from $145 at Truist
Truist raised the firm’s price target on Molina Healthcare (MOH) to $180 from $145 and keeps a Hold rating on the shares. The firm is adjusting its model to reflect…
Molina Healthcare price target raised to $163 from $144 at TD Cowen
TD Cowen raised the firm’s price target on Molina Healthcare (MOH) to $163 from $144 and keeps a Hold rating on the shares. The firm uodated its model following Q1…
Molina Healthcare price target raised to $159 from $141 at Wells Fargo
Wells Fargo analyst Stephen Baxter raised the firm’s price target on Molina Healthcare (MOH) to $159 from $141 and keeps an Overweight rating on the shares. The firm’s estimates are…
Molina Healthcare price target raised to $129 from $109 at Deutsche Bank
Deutsche Bank analyst George Hill raised the firm’s price target on Molina Healthcare (MOH) to $129 from $109 and keeps a Hold rating on the shares.
Molina Healthcare price target raised to $180 from $151 at UBS
UBS raised the firm’s price target on Molina Healthcare (MOH) to $180 from $151 and keeps a Neutral rating on the shares.
Molina Healthcare price target raised to $146 from $128 at Morgan Stanley
Morgan Stanley raised the firm’s price target on Molina Healthcare (MOH) to $146 from $128 and keeps an Equal Weight rating on the shares. EPS and enterprise MLR came in…
Molina Healthcare price target raised to $161 from $133 at Barclays
Barclays raised the firm’s price target on Molina Healthcare (MOH) to $161 from $133 and keeps an Underweight rating on the shares post the Q1 report.
Molina Healthcare of Iowa and The MolinaCares Accord Donate $100,000 to Support Senior Nutrition Food Program
WATERLOO, Iowa--(BUSINESS WIRE)--Molina Healthcare of Iowa and The MolinaCares Accord Donate $100,000 to support senior nutrition food program.
Molina Healthcare Earnings Call Transcript: Q1 2026
Q1 2026 delivered solid results with $2.35 adjusted EPS and $10.2B premium revenue. Full-year guidance is reaffirmed at ~$42B revenue and at least $5 EPS, despite higher Medicaid attrition, offset by Marketplace gains. Medical cost trends are stabilizing and capital position remains strong.